Search research articles
Contact Us
Filters
Showing results (131-140 of 137) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 137 results.
Neuroscience
|
October 18, 2008
A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1
P Imbrici, F Gualandi, M C D'Adamo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2003
The combination of yondelis and cisplatin is synergistic against human tumor xenografts
M D'Incalci, T Colombo, P Ubezio, et al.
Leukemia
|
November 14, 2008
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF
N Bolli, M F De Marco, M P Martelli, et al.
Leukemia
|
July 20, 2007
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML
M P Martelli, N Manes, V Pettirossi, et al.
The EMBO Journal
|
September 16, 1996
Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains
F Grignani, U Testa, D Rogaia, et al.
Leukemia
|
August 5, 2005
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin
H Quentmeier, M P Martelli, W G Dirks, et al.
Journal of Endocrinological Investigation
|
April 12, 2012
The use of local reference growth charts for clinical use or a universal standard: a balanced appraisal
S Milani, J M H Buckler, C J H Kelnar, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 137) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 137 results.
Neuroscience
|
October 18, 2008
A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1
P Imbrici, F Gualandi, M C D'Adamo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2003
The combination of yondelis and cisplatin is synergistic against human tumor xenografts
M D'Incalci, T Colombo, P Ubezio, et al.
Leukemia
|
November 14, 2008
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF
N Bolli, M F De Marco, M P Martelli, et al.
Leukemia
|
July 20, 2007
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML
M P Martelli, N Manes, V Pettirossi, et al.
The EMBO Journal
|
September 16, 1996
Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains
F Grignani, U Testa, D Rogaia, et al.
Leukemia
|
August 5, 2005
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin
H Quentmeier, M P Martelli, W G Dirks, et al.
Journal of Endocrinological Investigation
|
April 12, 2012
The use of local reference growth charts for clinical use or a universal standard: a balanced appraisal
S Milani, J M H Buckler, C J H Kelnar, et al.
Page
of 14